Market Place
Market Place
Post Enquiry
Celltrion`s Steqeyma (ustekinumab) Receives Approval in Europe
11 Sep 2024 //
EMA
Moderna Therapeutics`s mResvia Receives Approval in Europe
06 Sep 2024 //
EMA
ARS Pharmaceuticals`s Eurneffy (epinephrine) Receives Approval in Europe
05 Sep 2024 //
EMA
Strides Pharma`s Generics Theophylline Receives Approval in US
05 Sep 2024 //
FDA
XGen Pharm`s Generics Nelarabine Receives Approval in US
05 Sep 2024 //
FDA
Invagen Pharms`s Generics Linagliptin Receives Approval in US
03 Sep 2024 //
FDA
Roche`s Piasky (Crovalimab) Receives Approval in Europe
30 Aug 2024 //
EMA
Johnson & Johnson`s Balversa (Erdafitinib) Receives Approval in Europe
29 Aug 2024 //
EMA
Zydus`s Generics Scopolamine Receives Approval in US
29 Aug 2024 //
FDA
Qilu Pharmaceutical`s Generics Sugammadex Receives Tentative Approval in US
28 Aug 2024 //
FDA
Chartwell Pharma`s Generics Glycopyrrolate Receives Approval in US
28 Aug 2024 //
FDA
Lupin`s Generics Brimonidine Tartrate Receives Approval in US
26 Aug 2024 //
FDA
Alvotech`s Biologic Simlandi (Adalimumab) Receives Suppl Approvals in US
26 Aug 2024 //
FDA
AstraZeneca`s Biologic Beyfortus (Nirsevimab) Receives Suppl Approvals in US
22 Aug 2024 //
FDA
Novast`s Generics Mesalamine Receives Approval in US
22 Aug 2024 //
FDA
Indies Pharma`s Generics Regadenoson Receives Approval in US
22 Aug 2024 //
FDA
Alkem`s Generics Riluzole Receives Approval in US
22 Aug 2024 //
FDA
Zenara Pharma`s Generics Tafamidis Receives Tentative Approval in US
21 Aug 2024 //
FDA
Annora Pharma`s Generics Lurasidone Hydrochloride Receives Approval in US
21 Aug 2024 //
FDA
Eli Lilly`s Biologic Taltz (Ixekizumab) Receives Suppl Approvals in US
19 Aug 2024 //
FDA
Amgen`s Biologic Repatha (Evolocumab) Receives Suppl Approvals in US
19 Aug 2024 //
FDA
Amgen`s Biologic Amjevita (Adalimumab) Receives Suppl Approvals in US
19 Aug 2024 //
FDA
Dr. Reddy lab`s Generics Prednisone Receives Tentative Approval in US
08 Aug 2024 //
FDA
MSN Laboratories`s Generics Famotidine Receives Approval in US
06 Aug 2024 //
FDA
Somerset`s Generics Isoproterenol HCl Receives Approval in US
06 Aug 2024 //
FDA
Macleods Pharma`s Generics Canagliflozin Receives Tentative Approval in US
06 Aug 2024 //
FDA
Zenara`s Generics Valsartan Receives Approval in US
05 Aug 2024 //
FDA
Alembic`s Generics Acitretin Receives Approval in US
05 Aug 2024 //
FDA
GE Healthcare`s Generics Regadenoson Receives Approval in US
05 Aug 2024 //
FDA
Somerset`s Generics Trimethoprim Sulfate Receives Approval in US
05 Aug 2024 //
FDA
Torrent`s Generics Macitentan Receives Approval in US
05 Aug 2024 //
FDA
Lupin`s Generics Prednisolone Acetate Receives Approval in US
02 Aug 2024 //
FDA
Aurobindo Pharma`s Generics Estradiol Receives Approval in US
02 Aug 2024 //
FDA
Biocon`s Generics Lenalidomide Receives Tentative Approval in US
02 Aug 2024 //
FDA
QOL MEDCL`s Biologic Sucraud (Sacrosidase) Receives Suppl Approvals in US
02 Aug 2024 //
FDA
Ipca Laboratories`s Generics Etodolac Receives Approval in US
01 Aug 2024 //
FDA
Somerset Pharma`s Generics Ofloxacin Receives Approval in US
01 Aug 2024 //
FDA
Fresenius Kabi`s Generics Pantoprazole Sodium Receives Approval in US
01 Aug 2024 //
FDA
Alembic Pharmaceutical`s Generics Nelarabine Receives Approval in US
01 Aug 2024 //
FDA
Fresenius Kabi USA`s Generics Daptomycin Receives Approval in US
01 Aug 2024 //
FDA
BioMarin Biologic Brineura (Cerliponase Alfa) Receives Suppl Approvals in US
24 Jul 2024 //
FDA
AstraZeneca`s Biologic Imfinzi (Durvalumab) Receives Suppl Approvals in US
24 Jul 2024 //
FDA
AstraZeneca`s Biologic Imjudon (Tremelimumab) Receives Suppl Approvals in US
24 Jul 2024 //
FDA
Teva Pharma`s Generics Tiopronin Receives Approval in US
22 Jul 2024 //
FDA
Qilu`s Generics Meropenem Receives Approval in US
22 Jul 2024 //
FDA
Macleods Pharma`s Generics Cyclobenzaprine HCl Receives Approval in US
22 Jul 2024 //
FDA
Immunex`s Biologic Enbrel(Etanercept) Receives Suppl Approval in US
22 Jul 2024 //
FDA
Gland Pharma`s Generics Latanoprostene Receives Approval in US
22 Jul 2024 //
FDA
Samsung Bioepis`s Biologic Epysqli (Eculizumab) Receives Approval in US
19 Jul 2024 //
FDA
Amgen`s Wezenla (ustekinumab) Receives Approval in Europe
18 Jul 2024 //
EMA
Valneva`s Ixchiq (Chikungunya vaccine) Receives Approval In Europe
18 Jul 2024 //
EMA
Somerset Therapeutic`s Generic Zinc Sulfate receives Approval in US
17 Jul 2024 //
FDA
